Neurology
Our Specialists
Neuromuscular Disease Center
Emma Ciafaloni, M.D.
585-275-2541
585-275-4568
Current Titles and Roles
Associate Professor, Department of Neurology, Electromyography
Laboratory, and the Neuromuscular Disease Center
Degrees, Certifications,
and Licenses
- B.A., Liceo Classico A. Manzoni, Milan, Italy, 1983
- M.D., Universita’ Statale degli Studi of Milan, Italy,
1989
- Residency, Neurology, University of Milan, Italy, 1989-1993
- Post Doctoral Research Fellow, Laboratory of Neuromuscular
Diseases, Columbia University, New York, 1992
- Residency, Neurology, Duke University Medical Center, 1995
- Internship, Medicine, Duke University Medical Center, 1996
- Residency, Neurology, Duke University Medical Center, 1998
- Fellowship, Neuromuscular Diseases and EMG,
Duke University Medical Center, 2000
Prior Work History
-
2000-2002, Director MDA Clinic, Division of Neurology, Duke
University Medical Center
-
2001-2002, Assistant Professor of Medicine,
Department of Medicine, Division of Neurology, Duke University
Medical
Center
-
2000-2001, Instructor of Medicine, Department
of Medicine, Division of Neurology, Duke University Medical
Center
-
1992-1994, Associate Researcher, Division
of Neurology, Duke University Medical Center
Clinical Specialties
-
Providing care for adult and pediatric patients with neuromuscular
diseases such as Myasthenia Gravis, muscular dystrophies, ALS
and myopathies
-
Special interest in caring for women and children with Myasthenia
Gravis and muscular dystrophies
Highlights
Professional memberships:
American Academy of Neurology (AAN)
-
AAN Neuromuscular Section and the Muscle Study Group (MSG):
multi-center group dedicated to the planning and implementation
of controlled
clinical trials in neuromuscular diseases, member and
site investigator since 2000
-
American Association of Electrodiagnostic Medicine
-
Mycophenolate Mofetil in Myasthenia Gravis
-
Pathophysiology of Hypersomnolence in Myotonic Dystrophy
-
The Course and Outcome of Pregnancy in FSH
-
Phase III Trial of IGF-1 for ALS
-
Dichlorphenamide vs acetazolamide
for periodic paralysis
-
The goals of this multi-center
trial are to develop
standard treatments for the
periodic
paralyses,
to defend recommendations
for long-term treatments,
and to provide
data for regulatory
approval of dichlorphenamide.
Academic Activity
-
Teaching conferences for residents and fellows within the context
of the weekly electromyography laboratory conference and the
weekly neuromuscular disease conference
-
Teaching conferences for medical students and residents during
periods she serves as a general neurology consult and
inpatient attending
-
Providing periodic staffing support supervising residents
in the general neurology clinic
Comments
I have strong training and interest in the diagnosis, management,
and clinical therapeutic trials of patients with Myasthenia Gravis,
including children. I am particularly interested in the management
of women with Myasthenia gravis and muscular dystrophies as well
as children with muscular dystrophy.
|
|